No Carrier Added (nca) Lutetium Lu-177 Chloride
Generic Name: no carrier added (nca) lutetium lu-177 chloride
Dosage form: SOLUTION. Active ingredients: LUTETIUM LU-177 (20 Ci/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: SOLUTION. Active ingredients: LUTETIUM LU-177 (20 Ci/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as solution.
Related Medications
Echinacea, Hypericum, Valeriana, Aconitum Nap., Arsenicum Alb., Aur. Met., Baryta Carb., Benzoicum Ac., Berber. Vulg., Bryonia, Calc. Fluor., Cantharis, Ceanothus, Chelidonium Maj., Chionanthus, Cinchona, Convallaria, Crotalus Hor., Digitalis, Gelsemium, Glonoinum, Hydrofluoricum Ac. Kali Iod., Lachesis, Lycopus, Naja, Nux Vom., Phos., Pulsatilla, Rhus Tox., Vipera, Elaps.
echinacea, hypericum, valeriana, aconitum nap., arsenicum alb., aur. met., baryta carb., benzoicum ac., berber. vulg., bryonia, calc. fluor., cantharis, ceanothus, chelidonium maj., chionanthus, cinchona, convallaria, crotalus hor., digitalis, gelsemium, glonoinum, hydrofluoricum ac. kali iod., lachesis, lycopus, naja, nux vom., phos., pulsatilla, rhus tox., vipera, elaps.
Nitrogen Binding Agent [EPC]
OTC - PURPOSE SECTION Formulated for symptoms such as fear, cold hands & feet, headache, weakness, sallow skin and palpitations.
Inc-15-ruxo Phosphate
inc-15-ruxo phosphate
Dosage form: POWDER. Active ingredients: RUXOLITINIB PHOSPHATE (1 kg/kg). Category: BULK INGREDIENT.
Vorasidenib
vorasidenib
Isocitrate Dehydrogenase 1 Inhibitor [EPC]
11 DESCRIPTION VORANIGO tablets contain vorasidenib, an isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitor. Vorasidenib is present as the hemicitric acid hemihydrate co-crystal. The chemical name of the co-crystal is 6-(6-chloropyridin-2-yl)- N 2 , N 4 -bis[(2 R )-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine, 2-hydroxypropane-1,2,3-tricarboxylic acid, hydrate (2:1:1).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.